Aligos Therapeutics Inc
NASDAQ:ALGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
B
|
Bank of America Corp
DUS:NCB
|
US |
Wall St Price Targets
ALGS Price Targets Summary
Aligos Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALGS's stock price target?
Price Target
39.27
USD
According to Wall Street analysts, the average 1-year price target for
ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
118%
The compound annual growth rate for Revenue over the next 8 years is 118%.